In which phase of research is high-fidelity adherence data from smart blister packs most critical, as non-adherence can invalidate results?
Clinical trials (Phase I to Phase IV studies)
One of the most significant initial use cases targeted for this smart blister technology is within the execution of clinical trials, spanning Phase I through Phase IV studies. In these rigorous research environments, strict adherence to the established study protocol is absolutely non-negotiable because any deviation can compromise the validity and reliability of expensive and time-consuming research outcomes. Non-adherence is a recognized challenge in clinical research that frequently results in misleading conclusions regarding drug efficacy or safety profiles. By offering verifiable usage data, the smart pack serves as a direct countermeasure, ensuring researchers have objective measurements when assessing the true impact of an investigational drug.
